NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/23/2026
Back to search
Official data from USPTO
IPSOGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/24/2026
Trademark type
Word
Nice classes
5, 9
Filing date
02/20/2002
Registration date
06/07/2005
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/23/2026
Last transaction
03/24/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
1
Owner type
11
Owner location
HILDEN, DE
Examiner
CASE, LEIGH CAROLINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
QIAGEN GMBH
QIAGEN MARSEILLE S.A.S.
Q. M. (pessoa física)
IPSOGEN
Representatives
Daniel M. Gurfinkel Dennemeyer & Associates, LLC
Technical classification
Nice Classes
Class 5Class 9
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biological reagents for diagnoses and for identification of biological systems ; pharmaceutical productspreparationschemical preparations and chemico-pharmaceutical preparations for treating illnessesgenetic and infectious illnesses namelyacute leukemiaacute lymphoblastic leukemiaacute myelogenous leukemiaAMLacute monocytic leukemiaAMLacute promyelocytic leukemiaAPLadenocarcinomaadenocarcinoma lung canceradenocystic carcinomaadenoid cystic breast canceradenoid cystic arcinomaadrenal gland canceradvanced breast canceraggressive breast cancerameloblastomaanalanus cancer; angiosarcomaappendix cancerappendiceal cancerastrocytomaarrett's esophagusbartholin gland cancerbasal cell carcinomabasal cell skin cancerB-cell lymphomabilateral breast cancerbile duct cancerbladder cancerbladder metastasesbone cancerbone marrow transplantationBowen's diseasebone metastasesborderline ovarian cancerbrain metastasesbrain tumorbrainstem gliomabreast cancerbreast reconstructionbronchial cancerbronchioalveolar lung cancerbuttock cancercancer of unknown primary siteCUPScancer preventioncarcinoma of unknown primarycarcinoidcarcinoid syndromecarcinoid tumorcarcinosarcomacavernous sinus cancercecum cancercentral nervous system lymphomacentrocytic lymphomacerebral astrocytomacervix cancercervical cancerchest tumorsmediastinum tumorschiasmal gliomachildhood cancerschondromaintracranialchordomachondrosarcomachorioadenoma destruenschoroids plexus carcinomachoroidal melanomachronic leukemiachronic lymphocytic leukemiaCLLchronic myelogenous leukemiaCMLclear cell ovarian cancerclear cell sarcomaCNS lymphomacolon canceradenocarcinoma of the colonadenomatous polypspolypscolorectal cancercraniopharyngiomacutaneous T-cell lymphomaDCIS - ductal carcinoma in situdermatofibrosarcoma protuberansdesmoidtumordesmoplastic tumordiffuse lymphomadiffuselarge-cell lymphomaductal carcinoma in situDCISduodenalcancer dysgerminomaearly stage prostate cancerendocrine cancerendometrial cancerendometrial stromal sarcomaependymomaesophagus canceresophageal canceresophagus cancer of the gastroesophageal junctionesthesioneuroblastomaEwing's sarcomaextensive stage small cell lung cancerextrahepatic bile duct cancerextraskeletal chondrosarcomaextraskeletal Ewing's sarcomaextraskeletal osteosarcomaeye metastaseseye cancerfallopian tube cancerfibrosarcomafibrous histiocytomafollicular lymphomafollicularsmall-cleaved cell lymphomagallbladder cancergastric cancergastrinomagastro-esophagealGE junctioncancergastrointestinal lymphomaGE junction esophageal cancergerm cell tumorgestational trophoblastic diseasegiant cell bone tumorglioblastomagliomagliomatosisgranular lymphocytic lymphomagranulocytic leukemiagranulosa cell ovarian cancerhairy cell leukemiahead and neck cancerhemangioendotheliomahemangiopericytomahepatocelluar carcinomahigh-grade lymphomahigh-risk breast cancerhistiocytomamalignantHodgkin's diseaseHodgkin's disease in pregnancyhormone-refractory prostate cancerin situ breast cancerinsulinomaintermediate-grade lymphomaintraocular melanomainvasive lobular breast cancerislet cell pancreatic cancerKaposi's sarcomakidney cancerkrukenberg tumorlarge-cell lung cancerlarge-cell lymphomalarge-celldiffuse lymphomalarynx cancerlaryngeal cancerleiomyosarcomalentigo malignaleukemialinitis plasticalimited stage small cell lung cancerlip cancerliposarcomaliver cancerrecurrent liver cancerundifferentiated liver cancerlobular carcinoma in situLCISlobular hyperplasia low-grade lymphomalung cancernon-small cell lung cancerepidermoid carcinomalarge cell carcinomasquamous cell carcinomaspindal cell variantpancoast tumorssuperior sSulcus tumorsundifferentiated carcinomalung metastaseslymph node excisionlymphangitic metastasislymph node metastaseslymphoblastic leukemialymphoblastic lymphomalymphocytic lymphomalymphomanon-Hodgkin's lymphomamalignant ascitesmalignant hemangiopericytomamalignant fibrous histiocytomamalignant peripheral nerve sheath tumormalignant pleural effusionmalignant schwannomaMALT lymphomamantle cell lymphomamedlastinal tumormedulloblastomamelanomameningeal cancermeningeal metastasesmeningiomamerkel cell carcinomamerkel cell skin cancermesotheliomamesenchymal chondrosarcomametastatic melanomamixed mullerian tumormucinous carcinomamultiple myelomamuscle-invasive bladder tumormycosis fungoidesmyelodysplasiamyelodysplastic syndromemyelomaBence-Jonesmyeloproliferative disordernail/nail bed cancernasal cavity cancernasopharynx cancerneckradical dissectionneoplastic meningitisnerve sheath tumorsneuroblastomaneuroendocrine tumoradenosquamous carcinomaadenocarcinomaocular melanomaolfactory canceroligodendrogliomaoptic gliomaoral cancerorbital lumphomaorophaiynx cancerosteogenic sarcomaosteosarcomaovarian cancerPagets disease of the breastpancreatic cancerrecurrent pancreatic cancerborderline pancreatic tumorsmucinous cystic tumor with dysplasiaintraductal papillary mucinous tumor with dysplasiapseudopapillary solid tumorislet cell tumorsgastrinomaparagangliomaparanasal sinus cancerparaneoplastic syndromesparathyroid cancerparotid gland cancerpelvic tumorpenis cancerperiampullary cancerpericardial effusionperipheral nerve sheath tumorperipheral T-cell lymphomaperitoneal cancerextraovarian serous carcinomaextraovarian peritoneal serious papillary carcinomaserous surface carcinoma of the peritoneumserous surface papillary carcinomapapillary serous carcinoma of the peritoneummultiple focal peritoneal papillary carcinomaprimary peritoneal papillary serous adenocarcinomaperitoneal carcinomatosispheochromocytomapinealomapineoblastomaplasmacytomapleura cancerpleura metastasespreleukemiaprimary central nervous system lymphomaprimitive neuroctodermal tumorPNETplolymphocytic leukemiapromyelocytic leukemiaprophylactic mastectomyprostate cancerprostatic intraepithelial neoplasiaPINPSApseudomyxoma peritoneirectal cancerrecurrent colon cancerrecurrent colorectal cancerrecurrent lung cancerrecurrent melanomarecurrent ovarian cancerrecurrent prostate cancerrecurrent rectal cancerrelapsed lymphomarenal cell carcinomarenal pelvis cancerretinoblastomarhabdomyosarcomaRichters syndromerising PSA as an indication of recurrent prostate cancersalivary gland cancersarcoma of bonesarcomatoid carcinoma; sebaceous carcinomasezary syndromesinuscavernoussinus cancerskin cancerskin metastasessmall cell bladder cancersmall cell lung cancersmall cleaved cell lymphomasmall intestine cancersoft tissue lymphomasoft tissue sarcomasynovial sarcomaspinal cord cancerspindle cell thyroid cancersquamous cell cancernon-skinsquamous cell lung cancersquamous cell skin cancerstem cell transplantationstomach cancersuperficial bladder cancersweat glands cancerT-cell leukemiaT-cell lymphomacutaneoustesticular cancertestis cancerthalamuthalamicbrain tumorthymomathymus gland cancerthyroid cancerthyroid lymphomatongue cancertongue base cancertransitional cell cancer of renal pelvistransitional cell cancer of the ureterunknown primary cancerureter cancerurethra canceruterine canceruterine sarcomavagina cancervocal cord cancervulva cancerWaldenstrom's macroglobulinemiaWarthin's tumorWilms' tumorZollinger-Ellis syndrome
Class 9
Information processing devicescomputer keyboardsmousemonitorsreadersdata processing equipmentcompact disc playersoptical character readerscomputer memoriesprinters for use with computersprocessors; computer programs and software for stockagemanagementanalysis of biological information
Publications
History of USPTO decisions and trademark events.
45 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
03/23/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/23/2026
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/11/2026
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
03/04/2026
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
09/13/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/13/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
05/14/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/07/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/24/2020
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
12/15/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
12/15/2015
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
12/15/2015
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
12/15/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/15/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
10/19/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/07/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/14/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/14/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/14/2011
E815
TEAS SECTION 8 & 15 RECEIVED
06/02/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
06/07/2005
PUBO
PUBLISHED FOR OPPOSITION
03/15/2005
NPUB
NOTICE OF PUBLICATION
02/23/2005
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/21/2004
ALIE
ASSIGNED TO LIE
10/19/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2004
ACEC
AMENDMENT FROM APPLICANT ENTERED
10/07/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/22/2004
PAPER RECEIVED
09/22/2004
CNRT
NON-FINAL ACTION MAILED
06/04/2004
1.BD
Sec. 1(B) CLAIM DELETED
04/26/2004
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/26/2004
PAPER RECEIVED
04/26/2004
CNRT
NON-FINAL ACTION MAILED
10/23/2003
CFIT
CASE FILE IN TICRS
09/13/2003
CNSL
LETTER OF SUSPENSION MAILED
02/21/2003
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/13/2002
PAPER RECEIVED
12/13/2002
CNRT
NON-FINAL ACTION MAILED
06/19/2002
UNPR
UNRESPONSIVE/DUPLICATE PAPER RECEIVED
06/17/2002
DOCK
ASSIGNED TO EXAMINER
06/14/2002
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/15/2002
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/15/2002
PAPER RECEIVED
03/15/2002
Continuous trademark protection
Get notified about every new filing that threatens IPSOGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.